Add Yahoo as a preferred source to see more of our stories on Google. On Saturday morning, a major rockfall occurred on the North Face of the Eiger, covering the Swiss valley in a cloud of dust. A ...
Eiger BioPharmaceuticals, Inc. EIGR is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is ...
Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application ("NDA") to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...
Nicolas Hojac and Philipp Brugger have shattered a 21-year-old record, scaling the north faces of the Eiger, Mönch and Jungfrau in just 15 hours and 30 minutes. This is how they did it. Swiss pro ...
June 21 (Reuters) - Amylyx Pharmaceuticals (AMLX.O), opens new tab has agreed to buy the rights to bankrupt drugmaker Eiger BioPharmaceuticals' (EIGRQ.PK), opens new tab experimental drug for low ...
Eiger BioPharmaceuticals has said it will cut staffing numbers by 25% and refocus its R&D activities on metabolic diseases, after the FDA said it would need a new study on hepatitis delta virus (HDV) ...
The company will continue commercializing Zokinvy (lonafarnib) for Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies. Following a comprehensive review of programs, ...
The peak became famous in the 1930s when people would gather to catch glimpses of climbing parties ascending its vertical face THE Eiger – which translates as the Ogre- is is a 13,000ft mountain in ...
Eiger BioPharmaceuticals, Inc. EIGR announced that it has completed rolling submission of a new drug application (“NDA”) to the FDA for its pipeline candidate, lonafarnib. The NDA seeks approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results